Real-time enrollment status for this eosinophilic granulomatosis with polyangiitis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06046222 |
| Recruiting Status | Recruiting |
| Condition | Eosinophilic Granulomatosis With Polyangiitis |
| Phase | Clinical Trial |
| Target Enrollment | 45 participants |
| Active Locations | 7 sites in the US |
| Sponsor | NS Pharma, Inc. |
| Last Updated on CT.gov | May 22, 2025 (May 22, 2025) |
As of March 2, 2026: Clinical trial NCT06046222 is currently recruiting participants. This clinical trial study for eosinophilic granulomatosis with polyangiitis is actively seeking new participants at 7 locations across the United States. The study is sponsored by NS Pharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06046222 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06046222 was last updated May 22, 2025 (May 22, 2025). HelloStudys verifies this status automatically.